Articles with public access mandates - Anna OrlovaLearn more
Not available anywhere: 17
Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-ZEGFR:2377 Affibody molecule: aspect of the injected …
V Tolmachev, D Rosik, H Wållberg, A Sjöberg, M Sandström, M Hansson, ...
European journal of nuclear medicine and molecular imaging 37, 613-622, 2010
Mandates: Swedish Research Council
HEHEHE-Tagged Affibody Molecule May Be Purified by IMAC, Is Conveniently Labeled with [99mTc(CO)3]+, and Shows Improved Biodistribution with Reduced …
V Tolmachev, C Hofström, J Malmberg, S Ahlgren, SJ Hosseinimehr, ...
Bioconjugate chemistry 21 (11), 2013-2022, 2010
Mandates: Swedish Research Council
A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue
V Tolmachev, I Velikyan, M Sandström, A Orlova
European journal of nuclear medicine and molecular imaging 37, 1356-1367, 2010
Mandates: Swedish Research Council
Influence of labelling methods on biodistribution and imaging properties of radiolabelled peptides for visualisation of molecular therapeutic targets
V Tolmachev, A Orlova
Current medicinal chemistry 17 (24), 2636-2655, 2010
Mandates: Swedish Research Council
Use of a HEHEHE purification tag instead of a hexahistidine tag improves biodistribution of affibody molecules site-specifically labeled with 99mTc, 111In, and 125I
C Hofström, A Orlova, M Altai, F Wångsell, T Gräslund, V Tolmachev
Journal of medicinal chemistry 54 (11), 3817-3826, 2011
Mandates: Swedish Research Council
Gallium-68-labeled affibody molecule for PET imaging of PDGFRβ expression in vivo
J Strand, Z Varasteh, O Eriksson, L Abrahmsen, A Orlova, V Tolmachev
Molecular pharmaceutics 11 (11), 3957-3964, 2014
Mandates: Swedish Research Council for Environment, Agricultural Sciences and Spatial …
Comparative evaluation of two DARPin variants: effect of affinity, size, and label on tumor targeting properties
S Deyev, A Vorobyeva, A Schulga, G Proshkina, R Guler, J Lofblom, ...
Molecular pharmaceutics 16 (3), 995-1008, 2019
Mandates: Swedish Research Council
The emerging role of radionuclide molecular imaging of HER2 expression in breast cancer
V Tolmachev, A Orlova, J Sörensen
Seminars in cancer biology 72, 185-197, 2021
Mandates: Swedish Research Council, Vinnova, Sweden
Increasing the net negative charge by replacement of DOTA chelator with DOTAGA improves the biodistribution of radiolabeled second-generation synthetic affibody molecules
K Westerlund, H Honarvar, E Norrstrom, J Strand, B Mitran, A Orlova, ...
Molecular pharmaceutics 13 (5), 1668-1678, 2016
Mandates: Swedish Research Council
Comparative evaluation of affibody molecules for radionuclide imaging of in vivo expression of carbonic anhydrase IX
J Garousi, H Honarvar, KG Andersson, B Mitran, A Orlova, J Buijs, ...
Molecular pharmaceutics 13 (11), 3676-3687, 2016
Mandates: Swedish Research Council
Evaluation of the therapeutic potential of a HER3-binding affibody construct TAM-HER3 in comparison with a monoclonal antibody, seribantumab
A Orlova, TZ Bass, SS Rinne, CD Leitao, M Rosestedt, C Atterby, ...
Molecular Pharmaceutics 15 (8), 3394-3403, 2018
Mandates: Swedish Research Council
Radiolabeled probes targeting tyrosine-kinase receptors for personalized medicine
M Altai, A Orlova, V Tolmachev
Current pharmaceutical design 20 (14), 2275-2292, 2014
Mandates: Swedish Research Council
Optimized Molecular Design of ADAPT-Based HER2-Imaging Probes Labeled with 111In and 68Ga
S Lindbo, J Garousi, B Mitran, A Vorobyeva, M Oroujeni, A Orlova, ...
Molecular Pharmaceutics 15 (7), 2674-2683, 2018
Mandates: Swedish Research Council
Radiolabeled GRPR antagonists for imaging of disseminated prostate cancer-influence of labeling chemistry on targeting properties
B Mitran, V Tolmachev, A Orlova
Current Medicinal Chemistry 27 (41), 7090-7111, 2020
Mandates: Swedish Research Council
Structural and mutational analysis of member-specific STAT functions
F Erdogan, AK Qadree, TB Radu, A Orlova, ED de Araujo, J Israelian, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1866 (3), 130058, 2022
Mandates: Austrian Science Fund, Canadian Cancer Society, Canadian Institutes of …
Comparing the measured affinity of 111 In-labeled ligands for cellular receptors by monitoring gamma, beta, or X-ray radiation with three different LigandTracer® devices
Z Varasteh, A Orlova
Journal of Radioanalytical and Nuclear Chemistry 304, 823-828, 2015
Mandates: Swedish Research Council
[Tc (CO)]-(HE)-Z, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours.
A Orlova, C Hofström, J Strand, Z Varasteh, M Sandstrom, K Andersson, ...
European Journal of Nuclear Medicine & Molecular Imaging 40 (3), 2013
Mandates: Swedish Research Council
Available somewhere: 160
Pharmacologic inhibition of STAT5 in acute myeloid leukemia
B Wingelhofer, B Maurer, EC Heyes, AA Cumaraswamy, A Berger-Becvar, ...
Leukemia 32 (5), 1135-1146, 2018
Mandates: Austrian Science Fund, Natural Sciences and Engineering Research Council of …
Same-day imaging using small proteins: clinical experience and translational prospects in oncology
A Krasniqi, M D’Huyvetter, N Devoogdt, FY Frejd, J Sörensen, A Orlova, ...
Journal of Nuclear Medicine 59 (6), 885-891, 2018
Mandates: Research Foundation (Flanders), Swedish Research Council
Targeting of HER2-expressing tumors using 111In-ABY-025, a second-generation affibody molecule with a fundamentally reengineered scaffold
S Ahlgren, A Orlova, H Wållberg, M Hansson, M Sandström, R Lewsley, ...
Journal of nuclear medicine 51 (7), 1131-1138, 2010
Mandates: Swedish Research Council
Publication and funding information is determined automatically by a computer program